Pulmonary Vascular Diseases Unit, Papworth Hospital NHS Trust, Papworth Everard, Cambridgeshire CB3 8RE, UK.
Thorax. 2011 Apr;66(4):326-32. doi: 10.1136/thx.2010.147272. Epub 2011 Feb 5.
Anaemia is common in left heart failure and is associated with a poorer outcome. Many patients with pulmonary arterial hypertension (PAH) are anaemic or iron-deficient. This study was performed to investigate the prevalence of iron deficiency in PAH and to identify possible causes.
All patients with idiopathic or heritable PAH diagnosed in 1995-2008 were identified. Controls were selected from patients with chronic thromboembolic pulmonary hypertension (CTEPH). Full blood counts were examined and any abnormality was investigated. Patients were excluded if they had a cause for iron deficiency. The prevalence study was based on 85 patients with idiopathic PAH and 120 with CTEPH. A separate group of 20 patients with idiopathic PAH and 24 with CTEPH with matching haemodynamics were prospectively investigated for serum factors affecting iron metabolism.
The prevalence study identified a point prevalence of unexplained iron deficiency of 50% in premenopausal women with idiopathic PAH compared with 8% in premenopausal women with CTEPH (p=0.002); 14% in postmenopausal women with idiopathic PAH compared with 6% in postmenopausal women with CTEPH (p=0.16); 28% in men with idiopathic PAH men compared with 2% in men with CTEPH (p=0.002); and 60% in patients with heritable PAH. The serum study showed that patients with idiopathic PAH had lower serum iron and transferrin saturations than those with CTEPH. Interleukin-6 levels correlated with iron levels (r=-0.6, p=0.006) and transferrin saturations (r=-0.68, p=0.001) in idiopathic PAH but not in CTEPH.
The prevalence of unexplained iron deficiency is significantly higher in idiopathic PAH than in CTEPH. This may be linked to interleukin-6.
贫血在左心衰竭中很常见,与预后较差有关。许多肺动脉高压(PAH)患者存在贫血或铁缺乏。本研究旨在调查 PAH 患者铁缺乏的患病率,并确定可能的原因。
确定 1995-2008 年诊断为特发性或遗传性 PAH 的所有患者。对照组从慢性血栓栓塞性肺动脉高压(CTEPH)患者中选择。检查全血细胞计数,并对任何异常进行调查。如果患者有铁缺乏的原因,则将其排除在外。患病率研究基于 85 例特发性 PAH 患者和 120 例 CTEPH 患者。另外,前瞻性调查了 20 例特发性 PAH 患者和 24 例 CTEPH 患者,以确定影响铁代谢的血清因素。
患病率研究发现,与 CTEPH 相比,特发性 PAH 绝经前女性中未明原因铁缺乏的现患率为 50%(p=0.002),绝经后女性为 14%(p=0.16);特发性 PAH 男性为 28%,CTEPH 男性为 2%(p=0.002);遗传性 PAH 患者为 60%。血清研究表明,特发性 PAH 患者的血清铁和转铁蛋白饱和度低于 CTEPH 患者。白细胞介素-6 水平与铁水平(r=-0.6,p=0.006)和转铁蛋白饱和度(r=-0.68,p=0.001)相关,但在 CTEPH 中不相关。
特发性 PAH 中未明原因铁缺乏的患病率明显高于 CTEPH。这可能与白细胞介素-6 有关。